DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Gemcitabine
Gemcitabine
Hodgkin Lymphoma Treatment Regimens
A Phase I Trial of Pemetrexed Plus Gemcitabine Given Biweekly with B-Vitamin Support in Solid Tumor Malignancies Or Advanced Epithelial Ovarian Cancer Martee L
GEMCITABINE Hcl) for INJECTION
Intravesical Administration of Therapeutic Medication for the Treatment of Bladder Cancer Jointly Developed with the Society of Urologic Nurses and Associates (SUNA)
Cytostatics in Dutch Surface Water: Use, Presence and Risks To
Intravesical Gemcitabine Versus Mitomycin for Non-Muscle Invasive
Gemcitabine for Injection Should Be 5.2 Hematology Patients
Combination Treatment with Arsenic Trioxide and Sulindac Augments
Chemotherapy Regimens for Lymphoma
Gemcitabine-Containing Chemotherapy for the Treatment of Metastatic Myxofibrosarcoma Refractory to Doxorubicin: a Case Series
Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies
CYTOTOXIC and NON-CYTOTOXIC HAZARDOUS MEDICATIONS
Overview of the Current Treatment Strategy in Extranodal NK/T-Cell Lymphoma: from Diagnosis to Recurrence
GIAVPG Protocol
GEMZAR (Gemcitabine)
Cancer Drug Costs for a Month of Treatment at Initial Food
Injectable and Health Care Administered Oncology Medical Drug Criteria Through Preferred (Optional)
Diffuse Large B-Cell Lymphoma (Part 1 of 5)
Top View
Intravesical Gemcitabine and Mitomycin C Chemotherapy
Prognosis Small Cell Lung Cancer
Nab-Paclitaxel and Gemcitabine As First-Line Treatment of Advanced Or Metastatic Cholangiocarcinoma
Triplet Chemotherapy with Docetaxel, Gemcitabine and Liposomal
Chondroitin Sulphate Enhances the Antitumor Activity of Gemcitabine and Mitomycin-C in Bladder Cancer Cells with Different Mechanisms
Identification of Key Potential Targets and Pathway for Arsenic Trioxide by Systemic Bioinformatics Analysis in Pancreatic Cancer
Silverback Care Management CARE N' CARE Specialty Drug
Feasibility of 21-Day Continuous Infusion of Epirubicin in Hormone-Refractory Prostate Cancer Patients
Chemotherapy Extravasation Management
Hydroxyurea [CAS No
Nab-Paclitaxel (Abraxane) and Gemcitabine for Pancreatic Adenocarcinoma
Gemcitabine-Paclitaxel Albumin Bound (Abraxane) Ver1
Bladder Cancer Treatment Regimens
Epigenetic Cancer Therapy: Rationales, Targets and Drugs
Gemcitabine/Nab-Paclitaxel Versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: a European Multicenter Study
Gemcitabine and Cisplatin for Palliative Therapy of Urothelial
Chemogenomic Screening Identifies the Hsp70 Co-Chaperone HDJ2 As
Dacogen EMA Public Assessment Report
Phase I/II Study on Docetaxel, Gemcitabine and Prednisone In
DRUG NAME: Gemcitabine
Immunogenic Chemotherapy Using Cyclophosphamide and Gemcitabine
Emetogenic Potential of Antineoplastic Agents
LUNG CANCER TREATMENT REGIMENS (Part 1 of 7) Clinical Trials: the NCCN Recommends Cancer Patient Participation in Clinical Trials As the Gold Standard for Treatment
Computationally Predicting Clinical Drug Combination Efficacy With
Handling Cytostatic Drugs: Contents
Lung Cancer – Non-Small Cell (Nsclc)
GEMZAR Safely and Effectively
Strontium 89 Combined with Gemcitabine in Androgen-Resistant Prostate Cancer: Results of a Phase I-II Study
(Ddmvac) with Gemcitabine and Cisplatin (GC) As Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis
Immunotherapy and Combined Chemotherapy for Castration
Melatonin Enhances Arsenic Trioxide-Induced Cytotoxicity by Modulating Autophagy in an Acute Promyelocytic Leukemia Cell Line
Cytotoxic Effects of Gemcitabine-Containing Regimens Against Human Non-Small Cell Lung Cancer Cell Lines Which Express Different Levels of P185@ۥ1
Guidelines for the Use of Anti-Emetics with Chemotherapy
Cisplatin (70) Gemcitabine Ver1.1
SOFT TISSUE SARCOMA TREATMENT REGIMENS (Part 1 of 2)
Inhibiting Translation Elongation with SVC112 Suppresses Cancer Stem Cells and Inhibits Growth in Head and Neck Squamous Carcinoma
Global Oncology
Intravesical Gemcitabine Therapy for Nonmuscle Invasive Bladder Cancer
Gemcitabine & Cisplatin in Non- Small Cell Lung Cancer (NSCLC)
Hazardous Drug List
Compared Efficacy of Intravesical Bcg Vs Mitomycin-C, and Other Dual Therapies in Non-Muscle Invasive Bladder Cancer
Radiation Recall Phenomenon Associated with Arsenic Trioxide
BC Cancer Protocol Summary for First Line Treatment of Locally Advanced and Metastatic Pancreatic Cancer with Paclitaxel NAB (ABRAXANE) and Gemcitabine
Fourteen-Day Gemcitabine-Docetaxel Chemotherapy Is Effective and Safer Compared to 21-Day Regimen in Patients with Advanced Soft Tissue and Bone Sarcoma
Consensus Statement on Best Practice Management Regarding the Use of Intravesical Immunotherapy with BCG for Bladder Cancer Ashish M
Anticancer Dose Adjustment for Patients with Renal and Hepatic Dysfunction: from Scientific Evidence to Clinical Application
Apaziquone for Intravesical Instillation NDA 208714
Retrospection of the Effect of Hydroxyurea Treatment in Patients With